Search Results - "Fehling, Sarah K."

Acidic pH-Induced Conformations and LAMP1 Binding of the Lassa Virus Glycoprotein Spike by Li, Sai, Sun, Zhaoyang, Pryce, Rhys, Parsy, Marie-Laure, Fehling, Sarah K, Schlie, Katrin, Siebert, C Alistair, Garten, Wolfgang, Bowden, Thomas A, Strecker, Thomas, Huiskonen, Juha T

“…Lassa virus is an enveloped, bi-segmented RNA virus and the most prevalent and fatal of all Old World arenaviruses. Virus entry into the host cell is mediated…”
Get full text

Serological Evidence for the Circulation of Ebolaviruses in Pigs From Sierra Leone by Fischer, Kerstin, Jabaty, Juliet, Suluku, Roland, Strecker, Thomas, Groseth, Allison, Fehling, Sarah K, Balkema-Buschmann, Anne, Koroma, Bashiru, Schmidt, Kristina M, Atherstone, Christine, Weingartl, Hana M, Mettenleiter, Thomas C, Groschup, Martin H, Hoenen, Thomas, Diederich, Sandra

“…Many human ebolavirus outbreaks have been linked to contact with wildlife including nonhuman primates and bats, which are assumed to serve as host species…”
Get full text

Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans by Poetsch, Joseph H, Dahlke, Christine, Zinser, Madeleine E, Kasonta, Rahel, Lunemann, Sebastian, Rechtien, Anne, Ly, My L, Stubbe, Hans C, Krähling, Verena, Biedenkopf, Nadine, Eickmann, Markus, Fehling, Sarah K, Olearo, Flaminia, Strecker, Thomas, Sharma, Piyush, Lang, Karl S, Lohse, Ansgar W, Schmiedel, Stefan, Becker, Stephan, Addo, Marylyn M

“…This study investigates preexisting and vaccine-induced vector immunity in 30 participants of a Phase-1 VSV-EBOV Ebola vaccine trial. No preexisting immunity…”
Get full text

Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection by Dowall, Stuart David, Callan, Jo, Zeltina, Antra, Al-Abdulla, Ibrahim, Strecker, Thomas, Fehling, Sarah K., Krähling, Verena, Bosworth, Andrew, Rayner, Emma, Taylor, Irene, Charlton, Sue, Landon, John, Cameron, Ian, Hewson, Roger, Nasidi, Abdulsalami, Bowden, Thomas A., Carroll, Miles W.

“…The highly glycosylated glycoprotein spike of Ebola virus (EBOV-GP1,2) is the primary target of the humoral host response. Recombinant EBOV-GP ectodomain…”
Get full text

Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein Nanoparticle Vaccine With Matrix-M Adjuvant in Healthy Adults by Fries, Louis, Cho, Iksung, Krähling, Verena, Fehling, Sarah K, Strecker, Thomas, Becker, Stephan, Hooper, Jay W, Kwilas, Steven A, Agrawal, Sapeckshita, Wen, Judy, Lewis, Maggie, Fix, Amy, Thomas, Nigel, Flyer, David, Smith, Gale, Glenn, Gregory

“…Abstract Background Ebola virus (EBOV) epidemics pose a major public health risk. There currently is no licensed human vaccine against EBOV. The safety and…”
Get full text

Comprehensive Characterization of Cellular Immune Responses Following Ebola Virus Infection by Dahlke, Christine, Lunemann, Sebastian, Kasonta, Rahel, Kreuels, Benno, Schmiedel, Stefan, Ly, My L., Fehling, Sarah K., Strecker, Thomas, Becker, Stephan, Altfeld, Marcus, Sow, Abdourahmane, Lohse, Ansgar W., Muñoz-Fontela, César, Addo, Marylyn M.

“…The West African Ebola virus disease (EVD) outbreak was the largest EVD outbreak in history. However, data on lymphocyte dynamics and the antigen specificity…”
Get full text

Serological evidence of exposure to ebolaviruses in domestic pigs from Guinea by Fischer, Kerstin, Camara, Alimou, Troupin, Cécile, Fehling, Sarah K., Strecker, Thomas, Groschup, Martin H., Tordo, Noel, Diederich, Sandra

“…The genus Ebolavirus comprises several virus species with zoonotic potential and varying pathogenicity for humans. Ebolaviruses are considered to circulate in…”
Get full text

Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells by Kohli, Aneesha, Sauerhering, Lucie, Fehling, Sarah K, Klann, Kevin, Geiger, Helmut, Becker, Stephan, Koch, Benjamin, Baer, Patrick C, Strecker, Thomas, Münch, Christian

“…Acute kidney injury is associated with mortality in COVID-19 patients. However, host cell changes underlying infection of renal cells with SARS-CoV-2 remain…”
Get full text

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe by Agnandji, Selidji T, Huttner, Angela, Zinser, Madeleine E, Njuguna, Patricia, Dahlke, Christine, Fernandes, José F, Yerly, Sabine, Dayer, Julie-Anne, Kraehling, Verena, Kasonta, Rahel, Adegnika, Akim A, Altfeld, Marcus, Auderset, Floriane, Bache, Emmanuel B, Biedenkopf, Nadine, Borregaard, Saskia, Brosnahan, Jessica S, Burrow, Rebekah, Combescure, Christophe, Desmeules, Jules, Eickmann, Markus, Fehling, Sarah K, Finckh, Axel, Goncalves, Ana Rita, Grobusch, Martin P, Hooper, Jay, Jambrecina, Alen, Kabwende, Anita L, Kaya, Gürkan, Kimani, Domtila, Lell, Bertrand, Lemaître, Barbara, Lohse, Ansgar W, Massinga-Loembe, Marguerite, Matthey, Alain, Mordmüller, Benjamin, Nolting, Anne, Ogwang, Caroline, Ramharter, Michael, Schmidt-Chanasit, Jonas, Schmiedel, Stefan, Silvera, Peter, Stahl, Felix R, Staines, Henry M, Strecker, Thomas, Stubbe, Hans C, Tsofa, Benjamin, Zaki, Sherif, Fast, Patricia, Moorthy, Vasee, Kaiser, Laurent, Krishna, Sanjeev, Becker, Stephan, Kieny, Marie-Paule, Bejon, Philip, Kremsner, Peter G, Addo, Marylyn M, Siegrist, Claire-Anne

“…In this set of four phase 1 studies, a recombinant vesicular stomatitis virus (rVSV)–based Ebola vaccine induced Ebola virus–specific immune responses and was…”
Get full text

Acidic pH-Induced Conformations and LAMP1 Binding of the Lassa Virus Glycoprotein Spike: e1005418 by Li, Sai, Sun, Zhaoyang, Pryce, Rhys, Parsy, Marie-Laure, Fehling, Sarah K, Schlie, Katrin, Siebert, C Alistair, Garten, Wolfgang, Bowden, Thomas A, Strecker, Thomas, Huiskonen, Juha T

“…Lassa virus is an enveloped, bi-segmented RNA virus and the most prevalent and fatal of all Old World arenaviruses. Virus entry into the host cell is mediated…”
Get full text

Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization by Dahlke, Christine, Kasonta, Rahel, Lunemann, Sebastian, Krähling, Verena, Zinser, Madeleine E., Biedenkopf, Nadine, Fehling, Sarah K., Ly, My L., Rechtien, Anne, Stubbe, Hans C., Olearo, Flaminia, Borregaard, Saskia, Jambrecina, Alen, Stahl, Felix, Strecker, Thomas, Eickmann, Markus, Lütgehetmann, Marc, Spohn, Michael, Schmiedel, Stefan, Lohse, Ansgar W., Becker, Stephan, Addo, Marylyn M., Addo, Marylyn M., Becker, Stephan, Krähling, Verena, Agnandji, Selidji Todagbe, Krishna, Sanjeev, Kremsner, Peter G., Brosnahan, Jessica S., Bejon, Philip, Njuguna, Patricia, Siegrist, Claire-Anne, Huttner, Angela, Kieny, Marie-Paule, Modjarrad, Kayvon, Moorthy, Vasee, Fast, Patricia, Savarese, Barbara, Lapujade, Olivier

“…The recent West African Ebola epidemic led to accelerated efforts to test Ebola vaccine candidates. As part of the World Health Organisation-led VSV Ebola…”
Get full text